Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
CRTO Criteo SA
ATEX Anterix Inc
ALKT Alkami Technology Inc
PSX Phillips 66
PSA Public Storage
PRU Prudential Financial Inc
PPL PPL Corp
PNC PNC Financial Services Group Inc
PM Philip Morris International Inc
Go

Health Care : Biotechnology | Large Cap Value

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Price: Delayed
$115.08

Day's Change: 0.00 (0.00%)

Bid: --

Ask: --

B/A Size: --

Day's High: 115.56

Day's Low: 114.45

Volume (Light) Today's volume of 1,870,528 shares is on pace to be much lighter than ABBV's 10-day average volume of 5,722,228 shares.: 1,870,528

Yesterday's News, August 04, 2021
12:02 pm ET	JAMA Dermatology Publishes Data Showing RINVOQ(R) (upadacitinib) Achieved Superiority Versus DUPIXENT(R) (dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis(PR Newswire)
August 02, 2021
4:29 am ET	Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie(BusinessWire)
August 01, 2021
7:30 pm ET	Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie(BusinessWire)
July 30, 2021
7:44 am ET	AbbVie Reports Second-Quarter 2021 Financial Results(PR Newswire)
July 29, 2021
8:30 am ET	FDA Approves Expanded BOTOX(R) (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity(PR Newswire)
July 27, 2021
8:30 am ET	AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases(PR Newswire)
July 25, 2021
11:31 am ET	New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye Condition(PR Newswire)
July 23, 2021
12:38 pm ET	DALVANCE(R) (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients(PR Newswire)
July 21, 2021
1:00 am ET	Venetoclax (VENCLEXTA(R)) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS)(PR Newswire)
July 20, 2021
8:30 am ET	Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting(PR Newswire)
July 16, 2021
8:30 am ET	AbbVie Provides Update Regarding RINVOQ(R) (upadacitinib) for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S.(PR Newswire)
7:10 am ET	Chemical Peel Market to reach USD 67.81 million growth \| COVID-19 Impact and Analysis \| Technavio(PR Newswire)
July 15, 2021
8:28 am ET	Global Women's Healthcare Market Set to Witness Spells of Growth--Projected to Reach USD 46,163.5 Million by 2027(Globe Newswire)
July 14, 2021
4:33 am ET	Alzheimer's Drugs Market Report 2021-2028 \| Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report(Globe Newswire)
July 09, 2021
3:51 am ET	Pre Filled Syringes Global Market Report 2021: COVID-19 Implications And Growth(Globe Newswire)
July 08, 2021
4:06 pm ET	Collaboration Between AbbVie, Biogen and Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease(Thomson Reuters ONE)
4:06 pm ET	Collaboration Between AbbVie, Biogen and Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease(Globe Newswire)
July 07, 2021
9:30 pm ET	Biologic Therapeutics Market Fearuting AbbVie Inc. and AstraZeneca Plc \| Technavio(PR Newswire)
8:00 am ET	AbbVie to Host Second-Quarter 2021 Earnings Conference Call(PR Newswire)
July 02, 2021
5:19 am ET	Allergic Conjunctivitis Market Size 2021 \| Is Projected to Reach USD 3.60 Billion by 2028, Exhibiting a CAGR of 5.4%(Globe Newswire)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and